Acquired Company

Eliem Therapeutics acquired Tenet Medicines on June 27, 2024, with pre‑acquisition Tenet equityholders expected to own approximately 15% and pre‑acquisition Eliem equityholders approximately 85% of the combined company after the close and concurrent private placement.

Show more

Location: | Industry: | Sector:

Market Cap

0.00

52 Wk Range

$N/A - $N/A

Previous Close

$4.78

Open

$4.73

Volume

469,405

Day Range

$4.41 - $4.91

Enterprise Value

0.00

Cash

0.00

Avg Qtr Burn

N/A

Insider Ownership

0.00%

Institutional Own.

0.00%

Qtr Updated

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Budoprutug Details Kidney disease, Primary Membranous Nephropathy	Phase 1b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ETX-123 (Kv7.2/3 channel opener) Details Epilepsy, Seizures, Pain	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ETX-810 Details Chronic pain, Pain, Sciatica	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ETX-155 Details Epilepsy	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ETX-810 Details Chronic pain, Sciatica , Pain, Diabetes	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ETX-155 Details Major depressive disorder, Perimenopausal Depression	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.